Lawrence P. Wennogle

Corporate Officer/Principal at ITI, Inc. (New York)

74 year

Health Technology

Consumer Services

Profile

Lawrence P.
Wennogle is currently the Vice President-Drug Discovery at ITI, Inc. He previously worked as a Staff Scientist at Ciba-Geigy Corp.
and Novartis Pharmaceuticals Corp.
From 2003 to 2013, he was the Vice President-Drug Discovery at Intra-Cellular Therapies, Inc. He returned to the same position in 2013 and held it until 2019.
Dr. Wennogle received his undergraduate degree from Ithaca College and his doctorate from The University of Colorado in 1977.

Lawrence P. Wennogle active positions

Companies	Position	Start
ITI, Inc. (New York)	Corporate Officer/Principal	-

All active positions of Lawrence P. Wennogle

Former positions of Lawrence P. Wennogle

Companies	Position	End
INTRA-CELLULAR THERAPIES, INC.	Corporate Officer/Principal	2019-06-30
Intra-Cellular Therapies, Inc. /Old/ Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.	Corporate Officer/Principal	2013-09-25
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Corporate Officer/Principal	-
Ciba-Geigy Corp.	Corporate Officer/Principal	-

See the detail of Lawrence P. Wennogle's experience

Training of Lawrence P. Wennogle

The University of Colorado	Doctorate Degree
Ithaca College	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lawrence P. Wennogle's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INTRA-CELLULAR THERAPIES, INC.	Health Technology

Private companies	4
Intra-Cellular Therapies, Inc. /Old/ Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY.	Health Technology
Ciba-Geigy Corp.	Health Technology
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Health Technology
ITI, Inc. (New York)

See company connections